18
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Naproxen-induced Pseudoporphyria: Appearance of New Skin Lesions after Discontinuation of Treatment

, , &
Pages 108-111 | Received 23 Jul 1994, Accepted 12 Oct 1994, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Giorgia Martini & Francesco Zulian. (2006) Juvenile idiopathic arthritis: current and future treatment options. Expert Opinion on Pharmacotherapy 7:4, pages 387-399.
Read now

Articles from other publishers (21)

Robert P. E. Sarkany. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition 1 23 .
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 27 32 .
Amy S. Paller & Anthony J. Mancini. 2016. Hurwitz Clinical Pediatric Dermatology. Hurwitz Clinical Pediatric Dermatology 448 466.e4 .
Christine A. DeWitt, Kara M. Trapp & Melissa A. Muszynski. 2015. Dermatological Manifestations of Kidney Disease. Dermatological Manifestations of Kidney Disease 137 147 .
Amy S. Paller & Anthony J. Mancini. 2011. Hurwitz Clinical Pediatric Dermatology. Hurwitz Clinical Pediatric Dermatology 436 453 .
Adar T. Berghoff & Joseph C. EnglishIIIIII. (2010) Imatinib mesylate–induced pseudoporphyria. Journal of the American Academy of Dermatology 63:1, pages e14-e16.
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 2426 2429 .
Misty T. Sharp & Thomas D. Horn. (2005) Pseudoporphyria induced by voriconazole. Journal of the American Academy of Dermatology 53:2, pages 341-345.
Crossref
James T. Cassidy & Ross E. Petty. 2005. Textbook of Pediatric Rheumatology. Textbook of Pediatric Rheumatology 206 260 .
RICHARD HIFT & PETER MEISSNER. 2003. The Porphyrin Handbook. The Porphyrin Handbook 151 167 .
Diana S Milojevic & Norman T Ilowite. (2002) Treatment of rheumatic diseases in children: special considerations. Rheumatic Disease Clinics of North America 28:3, pages 461-482.
Crossref
Jeffrey R. LaDuca, Peter H. Bouman & Anthony A. Gaspari. (2016) Nonsteroidal Antiinflammatory Drug-Induced Pseudoporphyria: A Case Series. Journal of Cutaneous Medicine and Surgery 6:4, pages 320-326.
Crossref
Kevin J Murray & Daniel J Lovell. (2002) Advanced therapy for juvenile arthritis. Best Practice & Research Clinical Rheumatology 16:3, pages 361-378.
Crossref
Anthony J. Papadopoulos, Robert A. Schwartz, Zoltan Fekete, George Kihiczak, Joseph A. Samady, Suzanne H. Atkin & W. Clark Lambert. (2016) Pseudoporphyria: An Atypical Variant Resembling Toxic Epidermal Necrolysis. Journal of Cutaneous Medicine and Surgery 5:6, pages 479-485.
Crossref
Carl F. Schanbacher, Erin R. Vanness, Mazen S. Daoud, Ayalew Tefferi & W.P. Daniel Su. (2001) Pseudoporphyria: a clinical and biochemical study of 20 patients. Mayo Clinic Proceedings 76:5, pages 488-492.
Crossref
Catherine Litalien & Evelyne Jacqz-Aigrain. (2001) Risks and Benefits of Nonsteroidal Anti-Inflammatory Drugs in Children. Paediatric Drugs 3:11, pages 817-858.
Crossref
Justin J. Green & Steven M. Manders. (2001) Pseudoporphyria. Journal of the American Academy of Dermatology 44:1, pages 100-108.
Crossref
S.C. Lee, S.J. Yun, J-B. Lee, S-S. Lee & Y.H. Won. (2001) A case of porphyria cutanea tarda in association with idiopathic myelofibrosis and CREST syndrome. British Journal of Dermatology 144:1, pages 182-185.
Crossref
F. Antony & A.M. Layton. (2000) Nabumetone-associated pseudoporphyria. British Journal of Dermatology 142:5, pages 1067-1069.
Crossref
S. Mehta & B. Lang. (1999) Long-term followup of naproxen-induced pseudoporphyria in juvenile rheumatoid arthritis. Arthritis & Rheumatism 42:10, pages 2252-2254.
Crossref
Joachim Krischer, Flavio Scolari, Mitsuko Kondo-Oestreicher, Sonja Vollenweider-Roten, Jean-Hilaire Saurat & Marc Pechère. (1999) Pseudoporphyria induced by nabumetone. Journal of the American Academy of Dermatology 40:3, pages 492-493.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.